Results 31 to 40 of about 37,507 (250)

“The unpredictable ABSORB” – very late stent thrombosis of bioresorbable vascular scaffold

open access: yesHeart Views, 2019
Bioresorbable vascular scaffolds represent the next revolution in stent technology. They serve the dual purpose of antiproliferative drug delivery to vascular lumen like a drug-eluting stents (DES) as well as phased strut resorption over time leading to ...
Akshyaya Pradhan   +3 more
doaj   +1 more source

An Unusual Case of Stent-in-Stent Thrombosis

open access: yesJACC: Cardiovascular Interventions, 2015
A 71-year-old man was admitted for acute coronary syndrome. Six weeks earlier, he had a Promus Premier 3.0 × 12-mm (Boston Scientific, Natick, Massachusetts) drug-eluting stent (DES) implanted in the obtuse marginal (OM) artery for unstable angina. On repeat coronary angiography, haziness ([
Evelyn Regar   +3 more
openaire   +3 more sources

Predictors of Coronary Stent Thrombosis

open access: yesJournal of the American College of Cardiology, 2009
This study sought to comprehensively identify predictors of stent thrombosis (ST).Given the devastating consequences of ST, efforts should be directed toward risk stratification to identify patients at highest risk for ST.Consecutive patients with angiographic ST were enrolled. Patients who did not suffer from a ST were randomly selected in a 2:1 ratio
Werkum, J.W. van   +11 more
openaire   +4 more sources

Acute carotid stent thrombosis [PDF]

open access: yesJournal of Cardiovascular and Thoracic Research, 2018
Carotid artery stenting is a method used in the treatment of extracranial carotid artery stenosis that is becoming increasingly more common. Acute carotid thrombosis following CAS is a very rare and devastating complication that can be lethal for the patient unless treated immediately.
Arzu Kalayci   +5 more
openaire   +3 more sources

Early stent thrombosis confirmed in a cancer patient receiving regorafenib, despite triple antithrombotic therapy: a case report

open access: yesBMC Cardiovascular Disorders, 2021
Background While developments in oncology have lengthened survival in patients with cancer, such patients often develop cardiovascular diseases. Thus, percutaneous coronary intervention (PCI) is frequently undertaken in them.
Keisuke Shoji   +4 more
doaj   +1 more source

Case Report: INTRAPROCEDURAL STENT THROMBOSIS IN PERCUTANEOUS CORONARY ANGIOPLASTY

open access: yesFolia Medica Indonesiana, 2017
Stent thrombosis is a rare complication of PCI but associated with STEMI and sudden cardiac death. Intra procedural stent thrombosis (IPST) was defined new or increasing (compared with baseline) thrombus within or adjacent to a deployed stent occurring ...
Yudi Her Oktaviono
doaj   +1 more source

The Road to the Ideal Stent: A Review of Stent Design Optimisation Methods, Findings, and Opportunities [PDF]

open access: yes, 2023
Coronary stent designs have undergone significant transformations in geometry, materials, and drug elution coatings, contributing to the continuous improvement of stenting success over recent decades. However, the increasing use of percutaneous coronary intervention techniques on complex coronary artery disease anatomy continues to be a challenge and ...
arxiv   +1 more source

Stent Thrombosis With Drug-Eluting Stents

open access: yesJournal of the American College of Cardiology, 2013
First-generation drug-eluting stents (DES), which impart the controlled release of sirolimus or paclitaxel from durable polymers to the vessel wall, have been consistently shown to reduce the risk of restenosis and target vessel revascularization compared with bare metal stents (BMS).
T. Palmerini   +6 more
openaire   +3 more sources

Late Coronary Stent Thrombosis [PDF]

open access: yesCirculation, 2007
Introduced >20 years ago,1 coronary artery stents have improved the safety and particularly the efficacy of percutaneous coronary interventions (PCIs).2 Abrupt vessel closure, complicating 6% to 8% of balloon angioplasty procedures, was associated with a 5% mortality, 40% rate of myocardial infarction (MI), and 40% rate of emergency coronary artery ...
Bernhard Meier, Stephan Windecker
openaire   +3 more sources

A Synopsis of Stent Graft Technology Development [PDF]

open access: yesarXiv, 2023
Coronary artery disease (CAD) is a leading cause of death worldwide. Treatments have evolved, with stenting becoming the primary approach over bypass surgery. This article reviews the evolution of coronary stent technology, starting from the first angioplasty in 1977. Pioneers like Forssmann, Dotter, and Gruentzig established the foundation.
arxiv  

Home - About - Disclaimer - Privacy